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Immune cells are somewhat unique in that acti-
vation responses can alter quantitative phenotypes
upwards of 100,000-fold. To date little is known
about the metabolic adaptations necessary tomount
such dramatic phenotypic shifts. Screening for novel
regulators of macrophage activation, we found
nonprotein kinases of glucose metabolism among
the most enriched classes of candidate immune
modulators. We find that one of these, the carbohy-
drate kinase-like protein CARKL, is rapidly downre-
gulated in vitro and in vivo upon LPS stimulation in
both mice and humans. Interestingly, CARKL cata-
lyzes an orphan reaction in the pentose phosphate
pathway, refocusing cellular metabolism to a high-
redox state upon physiological or artificial downre-
gulation. We find that CARKL-dependent metabolic
reprogramming is required for proper M1- and M2-
like macrophage polarization and uncover a rate-
limiting requirement for appropriate glucose flux in
macrophage polarization.
INTRODUCTION
More than a century after the discovery of macrophages, our
understanding of the complexity of innate immune regulation
continues to expand (Medzhitov, 2010; Nathan and Ding,C2010). Major recent advances in deciphering macrophage func-
tion include the identification of functionally distinct macrophage
subtypes, pattern recognition receptors, and macrophages as
a functional interface, bridging adaptive and innate immune
responses (Gordon andMartinez, 2010; Janeway, 1989;Medzhi-
tov, 2009). Macrophages orchestrate a complex response to
external stressors and participate in tissue development,
homeostasis, and remodeling. These processes require activa-
tion of numerous signaling modules and dramatic alterations in
cell morphology and function (Martinon et al., 2009; Rock and
Kono, 2008). That said, surprisingly little is known of how energy
metabolism is reconfigured to support macrophage activation
and effector function.
The concept of cellular metabolic adaptation as a necessary
step for functional cellular reprogramming was first described
by Otto Warburg in 1924 (Warburg, 1956; Warburg et al.,
1924). His observation, that cancer cells primarily generate
lactate from glucose even in the presence of ample oxygen, is
thought to provide a bioenergetic balance buffering oxygen
availability, ATP demand, and carbon building block require-
ments for cell growth and division (Vander Heiden et al., 2009).
In analogy, CD8+ T cells, which also undergo substantial clonal
expansion, shift from oxidative metabolism in the resting state
toward anaerobic respiration upon activation (Fox et al., 2005;
Perl et al., 2002). Very recently, differentiation of Th17 cells and
dendritic cell activation was shown to rely on metabolic-reconfi-
guration (Beurel et al., 2011; Krawczyk et al., 2010; Shi et al.,
2011). In macrophages, increased lactate formation and activa-
tion of the pentose phosphate pathway (PPP) after phagocytosis
have been observed, suggesting potential importance of adap-
ted metabolism on the activation cascade (Drapier and Hibbs,ell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc. 813
Figure 1. Kinase Screen Reveals Distinct Metabolic Adaptation in Activated Macrophages
(A) Schematic of kinase screen.
(B and C) (B) Kinome modulation of LPS-induced (100 ng/ml; 1 hr) TNFa production (mean change ± SD) in RAW264.7 cells, including (C) kinases with known
immune regulatory functions. Dotted lines indicate screen cut-off.
(D) 21 Kinases exceeded the screen cut-off. Blue bars represent protein kinases (PK) and white bars nonprotein kinases (NPK). Kinases involved in primary
glucose metabolism are indicated by *.
(E) Enrichment analysis for Canonical Pathways.
(F and G) (F) Bone marrow-derived or thioglycollate-elicited macrophages were stimulated with LPS (100 ng/ml) or (G) IL-4 (10 ng/ml), and ECAR and OCR were
recorded.
(H and I) Dynamic (nonstationary) metabolic flux anaylsis of LPS or IL-4 stimulated BMDM by incubation with 100% labeled 13C-1-2-glucose. For abbreviations,
see text. (H) shows isotope incorporation rate (m+n/total/10min;m+n is all 13C-labeledmolecules irrespective of mass shift, and total is all labeled and unlabeled),
and (I) shows isotope distribution; ± SD, n = 5; *p < 0.05, **p < 0.01, ***p < 0.001.
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rats has been shown to influence the PPP in the liver (Kuttner
et al., 1982). To what extent proper macrophage activation
depends on bioenergetic rearrangement, however, remains
poorly understood.
In the current study, we use a screening strategy and identify
novel regulators of macrophage activation. We show that
specific modulation of glycolytic energy flux is critical to macro-
phage activation and defines polarity. A number of nonprotein
nutrient kinases appear critical in this setting, including CARKL,
which we show to be a sedoheptulose kinase of the pentose
phosphate pathway. Together, the findings establish a platform
for understanding how bioenergetics controls macrophage fate
and function.814 Cell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc.RESULTS
AFunctional Screen for Kinases Involved inMacrophage
M1 Polarization
In order to identify novel regulators ofmacrophage activation, we
performed an overexpression screen of 199 known or predicted
kinases of the human kinase ORFeome collection (Park et al.,
2005). Coding sequences for 122 protein kinases and 77 nonpro-
tein kinases were overexpressed in RAW264.7 macrophages
and LPS-induced changes in TNFa secretion monitored by
ELISA (Figures 1A and 1B and Table S1). Double-blind analysis
of the well-known activation-inducing kinases MAPKAPK3,
p38a, and AKT1 revealed prominent potentiation of the LPS-
induced TNFa-secretory response (Figure 1C; Kim et al., 2008;
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Metabolic Reprogramming in MacrophagesOjaniemi et al., 2003; Schieven, 2009). In contrast, robust inhib-
itory effects were observed for the known suppressive kinases
PKCd and HSP90-b (Figure 1C; Chen et al., 2005; Kim et al.,
2007; Salminen et al., 2008).
Based on the effect size of the double-blind control analysis
we set a conservative screen cut-off of ± 4 SDs (30% change
in TNFa) to determine candidate immunoregulatory kinases.
Twenty-one kinases exceeded the cut-off (Figure 1D). Overex-
pression of 16 kinases potentiated TNFa secretion. The remain-
ing five suppressed the TNFa response (Figure 1D). Interestingly,
substantial enrichment of nonprotein kinases over protein
kinases was observed in both the activating and suppressive
pools of candidate genes (white bars; Figures 1D and S1A).
Gene ontology analysis (IPA, Ingenuity) revealed top enrichment
scores for ‘‘organismal injury,’’ ‘‘inflammatory response,’’ path-
ways of cell signaling, and notably, carbohydrate and lipid
metabolism (Figure S1B and Tables S2 and S3). Most intrigu-
ingly, when analyzed according to classic canonical pathways,
5 of the top 8 pathways comprised core processes of primary
metabolism including glycolysis, fructose, mannose, and galac-
tose metabolism, mTOR signaling, and the pentose phosphate
pathway (Figure 1E and Table S4). The candidate immunoregu-
latory kinases responsible for this robust enrichment included
hexokinase 1 (HK1), ketohexokinase (KHK), phosphofructoki-
nase platelet-type (PFKP), phosphofructokinase muscle-type
(PFKM), and the recently described carbohydrate kinase-like
protein, CARKL (EMBL-Bank: AF163573.1). This robust signal
overlapped and was in agreement with the enrichment in
nonprotein kinases mentioned above (Figures 1D and S1A).
Thus, a panel of metabolic nonprotein kinases appears to control
macrophage activation.
Defining Cellular Glucose Flux during M1 and M2
Polarization
Considering the robust enrichment for metabolic kinases we
hypothesized a substantial reprogramming of metabolism
upon macrophage activation. To assess metabolic plasticity
upon activation, we recorded extracellular acidification rate
(ECAR) and oxygen consumption rate (OCR) in two types of non-
transformed primary mouse macrophages (bone marrow-
derived macrophages [BMDMs] and thioglycollate-elicited
macrophages). LPS stimulation, which drives an M1-like or clas-
sical activation pathway, increased ECAR and decreased OCR
(Figures 1F and S1C). IL-4, on the other hand, which triggers
M2-like activation, induced only a delayed andmarginal increase
in ECAR but did not affect OCR (Figure 1G). Thus, M1-activation
comprises robust metabolic reprogramming toward aerobic
glycolysis. To validate these findings, we used nonstationary
metabolic flux measurements to trace glucose fate within the
cell (Figures 1H and 1I). A 10min pulse of asymmetrically labeled
13C-1-2-glucose allowed simultaneous monitoring of the
pathway flux, origin of labeled metabolites, and thus flux-direc-
tionality. In agreement with the data above, LPS-stimulation
increased glycolytic-flux (production of glyceraldehyde-3-
phosphate [G3P], lactate [LAC] and glucose-6P/fructose-6P
[G6P/F6P]) (Figure 1H) and routed a substantial portion of glycol-
ysis-derived carbon into the PPP (m+2 ribose-5P/xylulose5-P
[R5P/X5P] in Figure 1I). High m+4 label in G6P/F6P further
indicated that glucose is rerouted via glycolysis to the PPP.CSedoheptulose-7-phosphate (S7P), a PPP-derived reaction
partner of G3P, displayed relatively high incorporation rates after
glucose incubation if compared to, e.g., lactate (Figure S1D). Of
note, we observed no significant increase in total S7P flux, but
isotopic distribution indicated a minor drop in the m+1 label
and a slight increase in m+2. The minor flux of glucose-derived
carbon to S7P indicates a small fraction of glucose-derived
S7P enters the PPP via G6PD. Increased PPP activity is associ-
ated with enhanced reduction of oxidized redox couples.
Indeed, LPS stimulation increased the formation of NADH (Fig-
ure 1H) and glutathione (GSH), a phenotype sensitive to
blockade of glucose-flux by DHEA or oxamate (Figure S1E).
The metabolic effect of M2-like activation by IL-4, however,
was marginal (Figures 1G–1I and S1C–S1E). Thus, classical
macrophage activation is characterized by increased glycolytic
and PPP flux.
Functional Reconfiguration of Cellular Metabolism
during M1 Polarization
A more detailed and time-resolved steady-state metabolomics
experiment was used tomonitor levels of intermediates in glycol-
ysis, the PPP and tricarboxylic acid cycle (TCA) (Figures 2A and
S2A). This approach revealed that LPS-induced polarization
induced rapid and significant decreases in X5P and R5P levels,
and a slower increase in S7P and G3P with time. These meta-
bolic intermediates constitute a PPP-glycolysis hub. Of note, in
the same 4 hr time-frame significant changes were observed in
acetyl coenzyme A (aCoA), succinate, and NAD/NADH ratio
(Figures 2A and S2B). These findings are supported by LPS-
induced ECAR and decreased OCR (Figures 2B and 2C). Again,
IL-4 induced only a minimal increase in ECAR but did not affect
OCR in both RAW264.7 and primary macrophages (Figures 2B,
2C, and 1G).
To test the relevance of metabolic reconfiguration during M1
polarization, we employed inhibitors to interfere with glucose
metabolism and measured cytokine production as a functional
readout. Importantly, blockade (by DHEA) of glucose-6-phos-
phate dehydrogenase (G6PD; rate limiting enzyme of the PPP),
glyceraldehyde-3-phosphate dehydrogenase (by iodoacetate),
and lactate production (by oxamate) significantly reduced
activation-induced TNFa and IL-6 production in RAW264.7
(Figures 2D and 2E, respectively) and primary (Figures S2C
and S2D, respectively) macrophages. These results confirm
a pivotal role for definedmetabolic rewiring and select metabolic
endpoints in M1 polarization.
CARKL Is a Candidate Immune Regulator In Vitro
and In Vivo
Our kinase screen identified CARKL as possible repressor of
LPS-induced macrophage activation. CARKL, in contrast to
the two currently known metabolic-kinases (HK, phosphofructo-
kinase), blocked TNFa production (Figure 1D). To begin to define
the role of CARKL in immune regulationwemeasured expression
kinetics in peripheral blood mononuclear cells (PBMCs) isolated
from volunteers following i.v. injection of LPS (2 ng/kg) (Marsik
et al., 2006) (Figure 3A). In this model of human endotoxemia
we detected a sharp transient decline of CARKL message
followed by normalization at 24 hr. TNFa expression peaked
2 hr post LPS administration. Similar downregulation andell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc. 815
Figure 2. LPS-Induced Polarization in Macrophages Results in a Functional Metabolic Adaptation
(A) Analysis of the initial M1-like activation phase by a steady-state metabolomic time-course in RAW264.7 empty vector control cells (pCtrl = 100%). In the
metabolic-pathway illustration, solid lines represent direct metabolite synthesis, whereas dashed lines indicate multiple enzymatic steps.
(B and C) (B) ECAR and (C) OCR recordings of RAW264.7 cells during LPS (100 ng/ml) or IL-4 (10 ng/ml) induced activation.
(D and E) (D) TNF-a and (E) IL-6 cytokine production of RAW264.7 cells pretreated with dehydroepiandrosterone (DHEA, 200 mM), oxamate (40 mM), or
iodoacetate (100 mM) 10 min before stimulation with 100 ng/ml LPS for 2 hr (TNF-a) or 6 hr (IL-6). All data represent mean ± SEM of at least three individual
experiments; n.d. = not detected, *p < 0.05, **p < 0.01, ***p < 0.001.
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importantly, in nucleated peripheral blood cells in LPS-injected
mice (Figure S3A). Thus, rapid CARKL downregulation is
a conserved response to acute LPS treatment in mice and
humans in vivo and in vitro.
In keeping with the marked in vivo regulation, we observed
a highly significant reduction in CARKL expression within
30 min post LPS stimulation in RAW264.7 cells (Figure 3B).
Messenger RNA levels were reduced by approximately 90%
after 2 hr. Interestingly, the timing of CARKL downregulation was
synchronous with induction of the prototypical M1 cytokines
interleukin IL-6 and IL-1b. To test specificity of the CARKL
response to LPS, we also induced macrophage polarization by
alternate activation pathways. Whereas primary murine macro-
phages polarized to anM1-like state showed a significant reduc-
tion in CARKL expression, activation with IL-4 or IL-13, agents
which drive ‘‘M2-like’’ responses, resulted in mildly increased
CARKL expression (Figure 3C). Together, these data strongly
suggest a role for CARKL modulation in macrophage polariza-
tion in vitro and in vivo in both mouse and man.816 Cell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc.CARKL Is a Sedoheptulose Kinase
Murine CARKL is a 476 amino acid (AA) protein containing an
FGGY carbohydrate kinase domain. Recent studies have sug-
gested that CARKL is a sedoheptulose kinase (converting sedo-
heptulose to sedoheptulose-7-phosphate) (Kardon et al., 2008;
Wamelink et al., 2008), though direct molecular proof for such
a role has been lacking. Using an ADP-accumulation assay, we
observed that the introduction of recombinant CARKL and ATP
resulted in ADP build-up in the presence but not absence of
sedoheptulose, direct evidence that CARKL possesses a sedo-
heptulose-dependent ATPase activity (data not shown). Further,
using thin layer chromatography we found that incubation of
CARKL with sedoheptulose and [32P]gATP produced radioac-
tively labeled sedoheptulose-phosphate (Figure 3D). Absence
of any single reactant resulted in the complete loss of labeled
product. Importantly, 31P-, 1H-, and 13C-NMR analysis of cold
reaction product (Figures 3E and S3B) specifically placed
CARKL phosphorylation of sedoheptulose at the C-7 carbon,
direct evidence of a sedoheptulose kinase activity necessary
to link glycolysis and the PPP. For an in-depth technical
Figure 3. Regulation, Function, and Structural Evaluation of CARKL
(A) Human CARKL and TNFa mRNA levels in PBMCs from healthy volunteers administered i.v. LPS (2 ng/kg).
(B) CARKL and cytokine mRNA expression in RAW264.7 cells incubated with LPS (100 ng/ml).
(C) CARKL expression in thioglycollate-elicited peritoneal macrophage polarized to either the M1- or M2-like phenotype by stimulation with LPS (100 ng/ml) in
combination with IFN (20 ng/ml) or by TNFa (25 ng/ml) for M1 and for M2 with IL-4 (20 ng/ml) or IL-13 (10 ng/ml) for 2 hr. Data represent mean ± SEM; *p < 0.05,
**p < 0.01, ***p < 0.001.
(D) Recombinant CARKL (rCARKL) formed sedoheptulose-phosphate (S-P) as shown by in vitro kinase assay with 32P labeled ATP resolved on thin layer
chromatography.
(E) 1H/13C HSQC spectrum of purified reaction product. X = residual HEPES buffer.
(F) Confocal fluorescence imaging of macrophages expressing CARKL_eGFP (green). Nuclei were visualized by DAPI (blue), and for colocalization cells were
stained for glucose-6-phosphate dehyrdogenase (G6PD) (red). Scale bar equals 5 mm.
(G) Simplified scheme of glucose metabolism indicating the central position of CARKL functioning as sedoheptulose kinase. Glucose-6-phosphate (G6P),
xylulose-5-phosphate (X5P), ribose-5-phosphate (R5P), dihydroxyacetone phosphate (DHAP), glyceraldehyde-3-phosphate (G3P), sedoheptulose-7-phosphate
(S7P), sedoheptulose (Sedo), pyruvate (PYR), lactate (LAC), and tricarboxylic acid cycle (TCA).
(H) Three-dimensional model for CARKL protein by comparative modeling. Insert shows opening of the central pocket.
(I) A representative result of computational sedoheptulose docking to CARKL presented in a 3D mesh model where the central cleft is centered and surface
accessibility sites are indicated by *. AA Q126, defined as flexible AA, is depicted in the inset.
(J) Amino acid (AA) sequence alignment of ATPase domain fragment from glycerol kinase (Glpk) sequence to CARKL (conserved AA red; similar AA green).
(K) Activities of recombinant CARKL point mutants for predicted critical AAs. Silver stain below bar graph indicated equal protein quantities.
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please refer to Figures S3B and S3C. In keepingwith this demon-
stration, we observed colocalization of CARKL with the first
enzyme of the PPP, glucose-6-phosphate dehydrogenase
(G6PD), and the metabolic scaffold protein tubulin, by confocal
microscopy (Figures 3F and S3D). Thus, CARKL bridges glycol-
ysis and PPP by catalyzing the formation of S7P from sedohep-
tulose (Figure 3G).
We next used a combination of homology- and comparative-
based in silico modeling to predict potential functional domains
and substrate interaction sites for CARKL. The resulting model
(Figures 3H and S3E), when combined with in silico substrate
docking experiments (Figure 3I), predicted several key features
for the enzyme-substrate complex: (i) a putative catalytic cleft
lies in the center of CARKL with two potential sedoheptulose
binding sites; (ii) one face of the cleft comprises a highly
conserved ATPase domain similar to that of glycerol kinase,
including a homologous pair of threonine residues (Glpk:
T13/T14; CARKL: T14/T15) for hydrogen bond formation with
ATP (Figure 3J); (iii) a highly flexible glutamine side chain
(Q126) separates the central cleft to form two pockets, A and B
(Figure 3I); (iv) sedoheptulose docking ranges from an extended
linear form in pocket B to a coiled open-chain structure in pocket
A (Figure 3I); (v) two additional potential access sites open into
pocket A (Figure 3I, asterisks); and (vi) a highly conserved trypto-
phan (W125) residue limits the internal space of the cavity (Fig-
ure 3H, insert). Importantly, this modeling exercise allowed us
to predict amino acid residues critical for CARKL activity. In order
to test the structural predictions, we generated point mutants of
the identified residues (W125D, Q126K, and T14M/T15K), puri-
fied the proteins, and tested them for their ability to phosphory-
late sedoheptulose (Figure 3K). Notably, all three mutants
showed substantially reduced sedoheptulose kinase activity,
strongly supporting the structural approach. Specifically, the
T14M/T15K mutant, predicted to impair ATP hydrolysis, as well
as the W125D substitution, which deforms and adds charge to
the catalytic cleft (Figure S3E), exhibited virtually complete abro-
gation of kinase function. Interestingly, activity of the potential
‘‘shuttling’’ mutant Q126K, while impaired, could be recovered
by addition of excess enzyme. All together, these data identify
CARKL as a sedoheptulose kinase and provide the first molec-
ular insights into its catalytic mechanism.
CARKL Focuses Glucose Metabolism and Marcrophage
Polarization
To investigate the necessity for CARKL in cellular metabolism
and ultimately M1 polarization, we generated a stable cell line
overexpressing CARKL (pCARKL; Figure 4A). Interestingly, me-
tabolomic profiling of naive pCARKL cells alone revealed signif-
icant alterations in intracellular metabolism, including reduced
G3P, R-5P, and X-5P levels (Figures 4B and S4A). These findings
implicate CARKL in control of metabolic state, and in particular
the nonoxidative arm of PPP. In a direct test of this idea, assess-
ment of OCR and ECAR revealed distinct and exclusive reduc-
tions in nonmitochondrial respiration (rotenone-resistant oxygen
consumption) in pCARKL cells, while ECAR levels were largely
unaffected (Figures 4C and S4B).
These findings suggest CARKL as a rheostat for cellular
metabolism. Using a CMV promoter to express CARKL, we818 Cell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc.reasoned that pCARKL cells would be largely unaffected by
LPS-induced CARKL downregulation, an ideal platform to test
the dependency of M1 polarization on CARKL downregulation.
Consistent with this hypothesis, pCARKL cells showed no
decrease in CARKL gene expression after LPS stimulation (Fig-
ure 4D). CARKL overexpression resulted in a severely blunted
‘‘proinflammatory’’ response. Specifically, IL-6, IL-1a, IL-1b,
TNFa, TNFsf15, MIP1a (Ccl3), MCP1 (Ccl2), CxCL2, and the
IL-13 receptor were repressed upon CARKL overexpression,
while TLR4 and CD11b remained unaffected (Figures 4E and
S4C). In contrast, the ‘‘anti-inflammatory’’ associated constitu-
ents IL-10, macrophage migration inhibitory factor (MIF), and
C-C motif cytokine 7 (Ccl7, MCP3), and IL-4R all showed exag-
gerated responses in the pCARKL cells after LPS. These data,
together with reduced MHC class II surface staining upon LPS
stimulation (Figure 4F), indicated a blunted M1-like activation
profile. Thus CARKL downregulation appears critical for proper
M1 polarization.
Next, we explored NFkB/SOCS/STAT3 signaling as well as
intracellular superoxide production rates, hallmark mech-
anistic features of M1-like activation. A luciferase reporter
assay revealed a moderately reduced basal and LPS-activated
NFkB transcriptional activity in pCARKL cells (Figure 4G),
a result confirmed by western blot analysis of nuclear RelA (Fig-
ure S4D). IkBa phosphorylation and degradation were not
affected (Figure S4E). Further, we observed decreased
SOCS3 mRNA expression (Figure 4H) and increased phosphor-
ylation of its target STAT-3 (Figure 4I) in pCARKL cells after
LPS stimulation. LPS-induced SOCS3 blocks activation of
STAT3, a transcription factor inhibitory to proinflammatory
mediator production (Murray, 2005). These findings are in
agreement with CARKL-induced repression of proinflammatory
gene expression. Similarly, measurement of intracellular super-
oxide production (O2
.-) rates using electron spin resonance
(Figure S4F) demonstrated severely blunted radical production
(Figure 4J), an effect apparently mediated by sustained S7P
formation (Figure S4G). These results indicated ‘‘proinflamma-
tory’’ signal transducers repressed and ‘‘anti-inflammatory’’
signals activated by CARKL.
CARKL Downregulation Is Required for M1-like
Metabolic Reprogramming
We next compared the ECAR and OCR response of LPS-acti-
vated pCARKL and control macrophages. Importantly, in
pCARKL cells initial LPS-induced ECAR elevation was unaf-
fected, but extension of this energetic state was blocked (Fig-
ure 5A). Again, this finding indicates that a more complex
biphasic metabolic reprogramming might be necessary for
proper macrophage activation. OCR levels reflected ECAR
changes in both control and pCARKL cells (Figure 5B).
Metabolomics performed after LPS activation revealed S7P,
X-5P, R5P, malate, and fumerate levels linked to CARKL expres-
sion (Figures 5C and S5A). An apparent build-up of S7P, X5P,
R5P, G3P, and G6P/F6P was observed, concomitant with
marked reduction in some TCA cycle intermediates and, impor-
tantly, NADH but not NAD+ levels (Figure 5D). Inmetabolic terms,
this equates to a lack of reducing equivalents to drive cellular
processes, a prominent increase in NAD/NADH ratio (Figure 5E),
and, thus, a marked imbalance in cellular redox state.
Figure 4. CARKL Reconfigures Cellular Metabolism and Represses Macrophage Activation
(A) CARKL protein expression levels in stable overexpressors (pCARKL) and empty vector control cells (pCtrl). Cell lines were derived from RAW264.7 cells.
(B) Metabolic intermediates in pCARKL cells relative to pCtrl cells.
(C) OCR and ECAR of pCARKL cells relative to pCtrl cells.
(D) CARKL expression in pCARKL cells in the presence and absence of LPS.
(E) Relative mRNA expression of (a) CARKL and classical LPS target genes ([b] receptors, [c] cytokines, [d] chemokines) following LPS (100 ng/ml) administration
(pCtrl, squares on black; pCARKL, triangles on blue).
(F) MHC class II surface expression of resting (basal, dashed lines) and LPS-activated (solid lines, for 24 hr) macrophages measured by FACS. Histogram is
representative of at least three independent experiments.
(G) NF-kB activity measured by a cis-reporting luciferase construct in pCARKL and pCtrl cells before and after activation with LPS (100 ng/ml) for 8 hr.
(H) SOCS3 and SOCS1 mRNA expression in pCARKL (blue) and pCtrl cells (black) relative to unstimulated pCtrl cells.
(I) Nuclear protein fraction from LPS-stimulated (2 hr) pCtrl and pCARKL cells was analyzed by western blot for the presence of phosphorylated STAT3 (STAT3-P)
and analyzed by densitometry.
(J) Quantification of intracellular superoxid (O2
.-) production rates in macrophages before and after LPS exposure (2 hr) measured by electron spin resonance
spectroscopy. Data are means ± SEM of at least three independent experiments; ns = not significant, *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 5. CARKL Integrates Redox State and Glucose Metabolism in Activated Macrophages
(A and B) ECAR and OCR during LPS activation of pCARKL and pCtrl cells.
(C and D) Metabolite profiles of pCtrl and pCARKL cells during initial activation phase (0–4 hrs post 100 ng/ml LPS). Solid lines represent direct metabolite
synthesis. Dashed lines indicate multiple enzymatic steps. Data represent delta mean change in % of pCARKL to pCtrl cells (pCtrl = 0%) ± SEM of three
independent experiments; to test if a metabolite profile was significantly changed, we used two-way ANOVA as the statistical test (indicated below metabolite
name); black line = pCtrl, blue line = pCARKL.
(E) Changes in NAD/NADH peak ratio during activation phase as fold change to unstimulated cells.
(F) GSH and GSSG of resting and LPS-activated (4 hr) pCtrl and pCARKL cells. Data are means ± SEM of three independent experiments; *p < 0.05, **p < 0.01,
***p < 0.001.
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substantially but GSSG only moderately (Figure 5F). IL-4 did
not induce such a redox dirft (Figure S5B). In pCARKL cells,
LPS induced a more robust increase in GSSG than in GSH,
despite a basal increase in the total glutathione pool. These find-
ings support the notion that CARKL acts as a regulator of cellular
metabolism and implicate CARKL as a necessary metabolic
catalyst for maintaining redox state during activation.820 Cell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc.CARKL Directs Macrophage Fate and Is Sufficient
for Activation
Given the findings above, we tested CARKL’s alleged metabolic
function in our macrophage activation model. LPS-induced IL-6
secretion and expression were significantly inhibited in pCARKL
cells versus pCtrl control cells (Figures 6A and 4E). Metabolic
regulation of IL-6 was also confirmed in primary macrophages
by incubation with metformin and rotenone (Figure S6A).
Figure 6. CARKL Regulation Directs the Macrophage Activation Process
(A) Macrophages overexpressing either wild-type or mutant CARKL were stimulated with LPS (100 ng/ml), and subsequent IL-6 secretion was measured in cell-
free supernatants 4 hr post activation.
(B) Protein expression levels of miCARKL and control (miCtrl) RAW264.7 cells.
(C) Relative bioavailability of metabolic intermediates in miCARKL and control cells.
(D–F) OCR and ECAR of miCARKL and miCtrl cells and their ECAR (E) and NAD/NADH ratios (F) relative to LPS-activated macrophages (1 hr).
(G–J) TNF-a (G) and IL-6 (H) cytokine secretion before and after LPS activation in miCARKL cells and miCtrl cells. Resting miCARKL and control cells were
incubated with Celastrol (1 mg/ml), DHEA (200 mM), oxamate (40 mM), and expression of TNFa (I) and Mrc-1 (J) was measured by RT-PCR.
(K) Mrc-1 expression by IL-4-stimulated miCtrl (black) and miCARKL (white) cells in the absence or presence of buthionine sulphoximine (BSO; 300 mM).
(L and M) TNF-a (L) and Mrc-1 (M) expression of IL-4 (10 ng/ml) activated pCARKL and pCtrl cells in the absence or presence of reduced glutathione ethyl ester
(GSH-Et; 5mM). Incubation timewas 4 hrs. Data are mean ± SEM of at least three independent experiments; nd = not detected, *p < 0.05, **p < 0.01, ***p < 0.001.
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Metabolic Reprogramming in MacrophagesOf note, overexpression of transaldolase 1 did not reverse
CARKL-mediated cytokine repression, though substitution of
galactose as the primary carbon source partly rescued this
effect (Figures S6B and S6C). This finding directly implicates
metabolic substrate flux as the primary determinant of CARKL’s
immunomodulatory effects. Most importantly, while overexpres-
sion of the catalytically active Q126K mutant recapitulated thisCmarked blunting of IL-6 secretion, the catalytically inactive
W125D mutant showed no effect whatsoever (Figure 6A). Thus,
the sedoheptulose kinase activity of CARKL is directly related
to outcome of macrophage polarization.
To ultimately test whether CARKL loss was an essential and
critical event for macrophage M1 polarization, we generated
CARKL knockdown (miCARKL) RAW264.7 cell lines (Figure 6B)ell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc. 821
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Metabolic Reprogramming in Macrophagesand tested for metabolic state and response to LPS (Figures 6C–
6H). In agreement with the pCARKL data above, miCARKL cells
accumulated intracellular G3P, X5P, and R5P levels (Figures 6C
and S4A) and reduced S7P levels. Sedoheptulose remained
unaffected. These findings support the idea that CARKL directly
controls carbon usage through a simple mass action. CARKL
loss promoted rerouting of glucose from aerobic to anaerobic
metabolism (Figures 6D and S4B) comparable to LPS induction
(Figure 6E). This was accompanied by a similar NAD/NADH ratio
(Figure 6F). Notably, LPS stimulation of miCARKL cells caused
a marked potentiation of the TNFa, IL-6, and IL-10 response,
direct evidence that CARKL downregulation promotes and
amplifies M1-like polarization (Figures 6G, 6H, and S6E). Again,
this effect was partly rescued by substitution of glucose to galac-
tose as the primary carbon source (Figure S6D). Further, in
resting miCARKL cells TNFa (high) and Mrc-1 (low) expression
patterns also paralleled LPS activation (Figures 6I, 6J, and
S1C), a phenotype resistant to oxamate but sensitive to NFkB
and PPP blockade. Together, these data suggested CARKL
loss as sufficient to induce a mild M1-like macrophage
polarization.
CARKL Sensitizes M2-like Polarization
In contrast to M1-like activation, M2-like activation of macro-
phages resulted in upregulation of CARKL (Figure 3C and
S1C). To investigate possible functional consequences of
CARKL level and M2-like polarization, we tested cells with either
low or high CARKL levels for basal and IL-4-induced Mrc-1
expression. miCARKL cells exhibited reduced Mrc-1 expression
(Figures 6J and 6K). Further, whereas IL-4 increased Mrc-1
expression around 40-fold in control cells, stimulation of
miCARKL cells increased Mrc-1 only to untreated control levels
(Figure 6K). Depleting GSH pools had no effect on IL-4-induced
Mrc-1 in control cells but significantly increased Mrc-1 expres-
sion in IL-4 treated miCARKL cells. This suggested altered redox
regulation by CARKL loss as one important factor involved in
Mrc-1 repression. In BMDM, pharmacologic activation of
glucose metabolism by metformin or rotenone totally blunted
IL-4 induced Mrc-1 expression (Figure S6G). In both primary
and RAW264.7 macrophages, alternative activation resulted in
downregulation of TNFa and upregulation of Mrc-1, a phenotype
exhibited by pCARKL cells under basal conditions and exagger-
ated upon IL-4 stimulation (Figures 6L, 6M, and S1C). Impor-
tantly, this pCARKL phenotype (TNFalow/Mrc-1high) was partly
sensitive to addition of exogenous GSH (GSH-Et), once again
implicating carbon flux and redox control in the functional
endpoint. Thus, CARKL sensitizes macrophages to M2
polarization.
DISCUSSION
Macrophage activation screening of 200 known and predicted
kinases revealed the surprising finding that some of the stron-
gest gene ontology enrichment was observed for pathways
regulating carbohydrate metabolism. Indeed, AKT1 and
STK11, both identified in our kinase screen, while classically
thought of as nutrient sensors, also control a fate switch, from
cytotoxic effector to memory CD8+ T cells (Finlay and Cantrell,
2011). More surprising was the robust enrichment of nonprotein822 Cell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc.kinases potentially capable of contributing directly to metabolic
flux through defined pathways. This finding, coupled with our
more detailed characterization of CARKL, supports a robust
interdependency of metabolism and immune cell function while
at the same time highlighting our overall lack of detailed knowl-
edge on the subject.
Indeed, cellular immune activation is a metabolically costly
endeavor and cannot operate effectively under energy deficit
(Demas et al., 1997). Among the nonprotein kinase candidates
observed to modulate TNFa secretion in our screen, HK, the
PFK family, and CARKL are strategically positioned to control
glucose usage according to cellular requirements. HK regulates
intracellular glucose availability. Fructose-1-6-bisphosphate
(F-1-6bp) formation by PFK is an irreversible step in glycolysis
that determines glycolytic flux and, not surprisingly, is the target
of potent antagonistic regulation by key metabolic hormones,
such as glucagon and insulin. Our work adds S7P formation by
CARKL as a novel rate-limiting lever for the system, balancing
the G3P and S7P intermediates of nonoxidative PPP and glycol-
ysis (Figure S7). Interestingly, a novel sedhoheptulose-1-7-
bisphosphatase, which forms S7P from S1-7bp, was very
recently reported as a crucial enzyme in yeast ribosome biogen-
esis with obvious consequences (Clasquin et al., 2011).
One particularly interesting observation was the highly signifi-
cant drop of NADH levels in pCARKL cells during macrophage
activation, which resulted in substantial redox shift (Figure 5D).
PPP activity contributes to reduction of redox couples via
NADPH. We therefore expected and observed increased GSH
and NADH generation during M1 activation, a phenotype that
could be reversed either by administration of DHEA to block
the PPP directly or by counterbalancing CARKL loss. M2-like
activation, on the other hand, resulted in an upregulation of
CARKL which was not followed by increased GSH or NADH
formation. These data represent a functional distinction between
the two polarization states that is, importantly, CARKL depen-
dent. Further, the pattern of baseline changes observed in
the pyridine pool in miCARKL and pCARKL cells (Figure S4A)
provides an interesting potential link to poly ADP-ribose
polymerase (PARP) protein family involvement. PARPs are
responsible for NAD degradation and important for immune
cell function, e.g., activation of NFkB (Oliver et al., 1999; Pollak
et al., 2007). In keeping with this idea, NADP pools were much
less affected than NAD in our system, a common feature of
PARP-mediated pyridine regulation (Pellny et al., 2009).
It has been reported that several master regulators of inflam-
mation are sensitive to ROS and that their function is dependent
on cellular redox states (Kazama et al., 2008; Kumar et al., 1992;
Toledano and Leonard, 1991; Wang et al., 1999). For instance,
NFkB is sensitive to cellular redox equilibrium (Perl et al.,
2002). This confirms the recent findings of Kawauchi and
colleagues reporting the bidirectional influence of NFkB and
glucose metabolism in cancer cell physiology (Kawauchi et al.,
2008). Interestingly, although CARKL reduced total active
NFkB, relative induction by LPS was only slightly affected. It
remains to be established how exactly CARKL and the NFkB
system rely on each other. We further report CARKL as negative
regulator of LPS-induced SOCS3 expression, without influ-
encing SOCS1 levels, but resulting in enhanced STAT3 phos-
phorylation. SOCS3 is commonly known as repressor of
Figure 7. CARKL Regulation of M1/M2 Activation
Schematic shows how CARKL may direct activation phases/fates of macro-
phages. CARKL directs carbon reshuffling (C-Flux) between glycolysis and
PPP (Figure S7). The resulting alteration in bioenergetics likely functions as
a regulatory system analogous to classical protein-based activation schemes
(as, for example, for inositol-phosphates). Dashed lines represent effects for
which direct evidence exists but where exact molecular mechanisms remain to
be defined.
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impacts the SOCS/STAT system (Figure 7). Specific SOCS
isoforms appear critical to eliciting pro- versus anti-inflammatory
macrophage states (O’Shea and Murray, 2008; Whyte et al.,
2011; Yoshimura et al., 2007).
And what of clinical relevance? Metabolic reconfiguration and
mildM1-like polarization are triggered by CARKL loss even in the
absence of additional stimulus. While the phenomenon is not
fully understood, cystinosis patients, who harbor a 57 kb deletion
affecting CARKL and CTNS, despite showing no strong signs of
inflammation, respond positively to continuous anti-inflamma-
tory treatment (Haycock et al., 1982). Further, our data may
provide insight into potential new modes of action for drugs
which clearly bridge both immune and metabolic signaling,
such as glucocorticoids and rapamycin.
In summary, this study identifies CARKL as a sedoheptulose
kinase orchestrating pro- and anti-inflammatory immune
responses through metabolic control. Our results highlight the
fundamental nature of metabolic reconfiguration in macrophage
activation and define unique metabolic demands of distinct acti-
vation states.
EXPERIMENTAL PROCEDURES
Reagents
Unless otherwise stated all reagentswere purchased fromSigma, all cytokines
from R&D Systems, and Celastrol from InvivoGen. [32P]g-ATP was a generous
gift of O. Hantschel (CeMM, Austria).
Cell Culture and Animals
RAW264.7 (ATCC) and all other cells were cultured in DMEMhigh glucose sup-
plemented with 10% heat-inactivated FBS and 50 mg/ml gentamycin. Thiogly-
collate-elicited mouse peritoneal macrophages were isolated as described by
Wassenberg et al. (1999). Bone marrow-derived macrophages were differen-Ctiated by 10% L929 conditioned media for 5 days or by recombinant murine
M-CSF (2ng/ml) (Figure S3A, lower left graph) as previously described
(Haschemi et al., 2007). Male C57BL/6J mice were purchased from JAX.
Kinase Screen
RAW264.7 macrophages were transfected using Lipofectamine 2000
(Invitrogen). Each individual human kinase ORF (Park et al., 2005) was trans-
fected to three wells. Twenty-four hours after transfection, cells were incu-
bated with 100 ng/ml LPS for 1 hr. Cell-free supernatant was assayed for
TNFa production. For further information please refer to Supplemental Exper-
imental Procedures.
Q-PCR
For Q-RT-PCR analysis, total RNA was extracted and reverse-transcribed
using commercial kits (QIAGEN, Applied Biosystems). All subsequent Q-RT-
PCRs were performed on an AbiPRISM 7900HT real-time cycler using iTaq
SYBRGreen Supermix with ROX (BioRad). For further information and primers
please refer to Supplemental Experimental Procedures and Table S2.
Cloning and Generation of Stable Cell Lines
A sequence-verified murine CARKL cDNA (clone MMM1013 OpenBiosys-
tems) lacking 50 and 30 UTRs was cloned into pcDNA6 (Invitrogen). miRNA-
adapted short hairpin RNA targeting mouse CARKL generated in pSM2 vector
(Open Biosystems, clone ID: V2MM_41673 F4) was subcloned into the LMP
vector. The pFUSE_eGFP plasmid was used to generate pCARKL_eGFP
fusion. All stable cell lines were derived from the RAW264.7 cell line. Refer
to Supplemental Experimental Procedures for further information.
Generation of Recombinant Mutant and Wild-Type CARKL
To generate recombinant wild-type or mutant CARKL, we employed in vivo
site-directed biotinylation as a purification strategy. The full-length open-
reading-frame of mouse CARKL or the mutant (W125D, Q126K, and T14M/
T15K; see below) was cloned into PinPoint Xa-1 vector (Promega) and purifi-
cation from E.coli was performed according to the PinPoint manual (Promega)
with final removal of the purification tag. For detailed information see Supple-
mental Experimental Procedures.
Sedoheptulose Isolation from Sedum spectabile
Sedoheptulose was isolated according to amodified protocol of Schmidt et al.
(1998). The final sedoheptulose preparation was 90% pure as measured by
NMR analysis (data not shown). For further information see Supplemental
Experimental Procedures.
Biochemical Characterization of CARKL Activity
We used the ADP Quest Assay (DiscoveRx) to indirectly measure S7P
formation by ADP accumulation over time. Radioactive kinase assays were
performed by incubating recombinant CARKL with [32P]g-ATP in kinase
reaction buffer (pH 7.6) containing 25 mM HEPES, 20 mM KCl, 10 mM
MgCl2, 10 mM ATP, and 10 mM sedoheptulose for 15 min at 30
C. The reac-
tion mixture was resolved on thin layer chromatography plates (Merck),
developed with MeOH:Chloroform:H20 (5:5:1) and subsequently exposed to
film. For purification of S7P please refer to Supplemental Experimental
Procedures.
Nuclear Magnetic Resonance
Nuclear magnetic resonance (NMR) spectra were recorded at 297 K on
a Bruker DPX 400 instrument at 400.13 MHz for 1H, 100.62 MHz for 13C, and
161.97 MHz for 31P using a 5 mm broad band probe with Z gradients. For
detailed information see Supplemental Experimental Procedures.
3D Modeling and Docking Experiments of CARKL
The model of CARKL was built based on the 3D structure of xylulose kinase
(PDB code: 2ITM) by usingMODWEB for homology and comparativemodeling
of protein 3D structures (Eswar et al., 2003; Pieper et al., 2009) with subse-
quent optimization. A detailed workflow for modeling and sedoheptulose
docking is accessible in Supplemental Experimental Procedures.ell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc. 823
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Total-cell lysates were prepared by harvesting cells in cell lysis buffer (50 mM
Tris-HCl [pH 7.6], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100). Proteins were
resolved on 4%–12%polyacrylamide gels (Invitrogen) and transferred to PVDF
membranes (Bio-Rad). Antibodies: anti-CARKL (ab69920, Abcam Inc.),
anti-Stat-P (Tyr705, clone D3A7), and anti-histone H3 (clone D1H2) (Cell
Signaling Technology), and anti-b-Actin (A5316, Sigma). Nuclear fractions
were prepared using Nuclear Extraction Kit (Panomics).
Site-Directed Mutagenesis
Expression plasmids PinPoint Xa_CARKL (bacterial expression) and
pCARKL (eukaryotic expression), containing the mouse CARKL cDNA
were mutated using the QuickChange site-directed mutagenesis kit II
(Stratagene).
FACS
Cells were incubated with FITC-labeled mAb MHC class II (Invitrogen).
More than 0.5 3 105 cells were analyzed by flow cytometry (FACSCalibur;
BD). Surface marker analysis was performed using FlowJo software (Tree
Star, Inc.).
Confocal Laser Scanning Microscopy
Stable CARKL_eGFP-expressing macrophages were cultured in tissue
culture-treated glass slides (BD Falcon), and specimens were then examined
after staining using a Zeiss LSM5 laser scanning Microscope (Carl Zeiss
Optics). A detailed protocol is accessible in Supplemental Experimental
Procedures.
Luciferase Reporter Assay
PathDetect NFkB cis-reporting luciferase plasmid for measuring transcription
factor activation contained a basic TATA box in addition to five repetitive NFkB
enhancer element binding sites (Stratagene). RAW264.7 cells were seeded
into 48-well plates and transfected 1 day thereafter at 1.0 mg/well of reporter
construct using Superfect reagent (QIAGEN) according to the manufacturer’s
instructions. Twenty-four hours later, cells were treated with or without LPS
(100 ng/ml). After 8 hr, protein extracts were quantified for normalization and
assessed for luciferase activity (Promega) according to the manufacturer’s
instructions.
GSH and GSSG Measurements
Oxidized and reduced glutathione were measured using GSH/GSSG-Glo
assay provided by Promega according to provided protocol.
Cytokine Measurements
TNF-a and IL-6 levels in cell culture supernatants weremeasured usingMouse
TNF-a/Tnfsf1a and IL-6 Quantikine ELISA Kits purchased from R&D Biosys-
tems, according to the protocol provided by the manufacturer.
Electron Spin Resonance
We employed CMH (1-Hydroxy-2,2,5,5-tetramethyl-pyrrolidine-3-carboxylic
acid methyl ester) spin probe (Noxygen) to measure absolute superoxide
generation rates in real time (Figure S4F) using a Bruker EMX spectrometer.
For detailed protocol see Supplemental Experimental Procedures.
Cellular Respiration and Extracellular Acidification
XF24 Extracellular Flux Analyzer (Seahorse Biosciences) was used to deter-
mine the bioenergetic profile of intact cells (Spolarics and Wu, 1997). Briefly,
cells were seeded (70,000 cells/well) in XF24 plates and allowed to recover
for 24 hr before the OCR and ECAR were assessed in glucose-containing
media (Seahorse Biosciences). Results were normalized to the actual cell
count immediately after OCR and ECAR recordings.
Metabolomic Analysis
Metabolites were extracted from cells by 80/20 methanol/water solvent, sepa-
rated via hydrophilic interaction liquid chromatography (HILIC), and detected
online using an Agilent 6410 Triple Quadrupole mass spectrometer (MS/MS)
with an electrospray ionization (ESI) source, as detailed in Supplemental
Experimental Procedures.824 Cell Metabolism 15, 813–826, June 6, 2012 ª2012 Elsevier Inc.Flux Analysis
Control, LPS (100 ng/ml, 1 hr), or IL-4 (10 mg/ml, 2 hr) stimulated pri-
mary macrophages (BMDM) were incubated with 100% 13C-1-2-glucose-
containing media for exactly 10 min and subsequently quenched with liquid
nitrogen. Carbon-13 mass isotopomer analysis of metabolites was carried
out using liquid chromatography-mass spectrometry (LC-MS), according to
the protocol of Lorenz et al. (2011), as detailed in Supplemental Experimental
Procedures.
Human and Murine In Vivo Models of Endotoxemia
We employed banked human PBMC mRNA samples (n = 6) from a previously
published study where participants received an intravenous bolus containing
2 ng/kg LPS (Marsik et al., 2006). For sublethal murine in vivo endotoxemia,
we injected 50 mg/kg LPS (Sigma) into the tail vein of male C57BL/6J mice
and isolated PBMCs from mice before and after LPS injection (n = 3–4).
All animal experiments were carried out according to an ethical animal
license protocol and contract approved by the Medical University Vienna
(BMWF-66.009/0140-II/10b/2010).
Statistical Analyses
All data unless otherwise indicated are shown asmean ± SEM andwere tested
using two-tailed Student’s t test or ANOVA (p < 0.05). All figures and statistical
analyses were generated using GraphPad Prism 4.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, five tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.cmet.2012.04.023.
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